InvestSMART

Betashares Global Healthcare ETF - Currency Hedged (ASX: DRUG) - Share Price and Research

- Current share price for DRUG : $8.650

Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

DRUG General Information +

ASX Code DRUG
Website http://www.betashares.com.au
Industry/Sector Asset Management & Custody Banks
Market Cap ($M) 172
DRUG Share Price $8.650
Day High $8.670
Day Low $8.630
Last Close $8.650
DRUG Share Price Movement - ( No change )
Prices as at 16:40, 27 May 2024
+Security prices are delayed by at least 20 minutes and are indicative only.

DRUG Related Research

Exchange Traded Fund Description

Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 2.67¢ 0% 2 Jan 2024 17 Jan 2024 $8.650 $8.710 -
Result 2.62¢ 0% 3 Jan 2023 18 Jan 2023 $8.650 $8.710 -
HFResult 0% 1 Jul 2022 18 Jul 2022 $8.650 $8.710 -

See all dividends from Betashares Global Healthcare ETF - Currency Hedged (DRUG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Units on Issue Disclosure - April 2024 6 May 2024 3:20PM $8.430 $8.650 $8.710 risen by 2.61%
Units on Issue Disclosure - March 2024 5 Apr 2024 4:24PM $8.370 $8.650 $8.710 risen by 3.35%
Interim Financial Report 14 Mar 2024 8:50AM $8.650 $8.650 $8.710 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Betashares Global Healthcare ETF - Currency Hedged (DRUG) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

DRUG Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2023A $6.99 $34.60 366.60% 22.10 2.60 0.30% 0.0%
2022A $1.57 $7.40 -92.80% 103.70 1.90 0.30% 0.0%
2021A $15.13 $103.50 109.70% 6.70 36.60 5.30% 0.0%

DRUG Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2021 A 2022 A 2023 A 2021 A 2022 A 2023 A 2021 A 2022 A 2023 A
Betashares Global Healthcare ETF - Currency Hedged (DRUG) $173M 3.6658 0.0000 0.0000 25.1011 0.0000 0.0000 0.30% 0.00% 0.00%
Magellan Financial Group (MFG) $1,516M -0.5164 -0.0458 -0.1145 8.3858 8.7881 9.9243 13.91% 6.75% 5.98%
Netwealth Group (NWL) $4,942M 0.1948 0.3656 0.1744 73.5294 53.8421 45.8456 1.19% 1.58% 1.85%
Pinnacle Investment Management Group (PNI) $2,651M -0.0127 -0.0682 0.2111 33.4615 35.9108 29.6524 2.76% 2.51% 2.70%
Perpetual (PPT) $2,498M -0.2217 0.0366 0.1016 13.1335 12.6699 11.5015 7.05% 5.91% 6.36%

DRUG Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 25.00 1.10 0.00
Market 0.48 14.40 1.09 1.02
Sector 0.00 0.00 0.00 0.00

DRUG Directors

Name Position Start Date
Mr Alex Vynokur Executive Director 21 Sep 2009
Mr Jason Gellert Executive Director 5 Mar 2021
Mr Edward Sippel Non-Executive Director 5 Mar 2021

Betashares Global Healthcare ETF - Currency Hedged (DRUG) Changes in Directors' Interest & Trades

There are no directors' trades from Betashares Global Healthcare ETF - Currency Hedged (DRUG). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

FAQs about Betashares Global Healthcare ETF - Currency Hedged (DRUG)

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current share price is $8.65. This constitutes a price movement of 0.69% when compared to the share price 7 days ago and is -1.03% below DRUG's 12-month high of $8.74 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $8.65, Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current share price of $8.65 constitutes a movement of or 0%. Betashares Global Healthcare ETF - Currency Hedged's (DRUG) share price movement is -0.69% when compared to 7 days ago and is -1.03% below DRUG's 52-week high of $8.74.

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) 52-week high is $8.74 which was reached on 16 May 2024. Relative to this, DRUG's current share price of $8.65 constitutes a -$0.09 or -1.03% drop since that high of $8.74 per DRUG share.

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) 52-week low is $7.32 which was reached on 30 Oct 2023. Relative to this, DRUG's current share price of $8.65 constitutes a $1.33 or 18.17% gain since that low of $7.32 per DRUG share.

Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current market capitalisation is $172,109,967. Market capitalisation, sometimes referred to as "market cap", is the total value of a company's or ETF's issued shares or units owned by shareholders or unitholders. Market capitalisation is equal to the market price per share or unit multiplied by the number of shares or units outstanding.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) last distribution or dividend was $0.03 per share and was paid on 17 Jan 2024. This last DRUG distribution or dividend included 0% franking.

Upcoming ex-distribution date: 2 Jan 2024

Upcoming record date: 3 Jan 2024

Upcoming payment date: 17 Jan 2024

ETFs, such as Betashares Global Healthcare ETF - Currency Hedged (DRUG), pay distributions instead of dividends. The difference is that dividends are declared by companies from part of the profits made during any given year and the company’s management decide the amount of earnings retained verses how much to pay out to investors. An ETF, like Betashares Global Healthcare ETF - Currency Hedged (DRUG), must pay out all realised income. This is a combination of any dividends received plus capital gains realised from the buying and selling of underlying holdings within Betashares Global Healthcare ETF - Currency Hedged (DRUG).


A distribution has three key dates:

Ex-distribution date: Date the distribution value leaves the ETF. This will normally correspond with the ETF unit price dropping in value by the same amount as the distribution.

Record date: Date someone must be on the unit registry to receive the distribution.

Payment date date: Date the distribution is paid to the unit holder.

Betashares Global Healthcare ETF - Currency Hedged (DRUG) has a current dividend yield of n/a this year. Last year's dividend yield was 0.30%. The dividend yield for DRUG is a ratio that tells you the percentage of Betashares Global Healthcare ETF - Currency Hedged (DRUG)'s share price that it pays out in dividends each year. The dividend yield is calculated by dividing the annual dividends by the current share price.

The "management expense ratio" (MER) for Betashares Global Healthcare ETF - Currency Hedged (DRUG) is 0.57%. This is the total expense for operating an ETF or managed fund like Betashares Global Healthcare ETF - Currency Hedged (DRUG). This includes management fees and other operating expenses which all come out of an investor's return.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.